Desq Long
Sign in

This filing is an amendment. It supersedes 0000886982-26-000495, which remains published.

SEC FORM 4
$4,410.00

Attovia Therapeutics, Inc. (ATTO)

Sale of 200 shares at $22.05 per share.

Reporting Persons GOLDMAN SACHS GROUP INC · GOLDMAN SACHS & CO. LLC · GOLDMAN SACHS ASSET MANAGEMENT, L.P. · Broad Street Principal Investments, L.L.C. · WSLS OFFSHORE INVESTMENTS, SLP · West Street Life Sciences I, L.P. · WSLS EMP OFFSHORE INVESTMENTS, L.P. · WSLS EMP ONSHORE INVESTMENTS, L.P. · Transaction Code S

Traded Aug 5, 2026 · Disclosed Aug 28, 2026FILED +23 DAYS

Source: SEC Form 4 · 0000886982-26-000522 · filed 2026-08-28 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Attovia Therapeutics, Inc. (ATTO)." Disclosed 2026-08-28. https://desqlong.com/cards/0000886982-26-000522-5 (retrieved 2026-09-26).